Related references
Note: Only part of the references are listed.Development and Validation of a Lung Cancer Risk Prediction Model for African-Americans
Carol J. Etzel et al.
CANCER PREVENTION RESEARCH (2008)
A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers
Shanbeh Zienolddiny et al.
CARCINOGENESIS (2008)
Genetic variation in CYP17 and endometrial cancer risk
Mia M. Gaudet et al.
HUMAN GENETICS (2008)
Oestrogen receptor beta over expression in maces with non-small cell lung cancer is associated with better survival
Birgit Guldhammer Skov et al.
LUNG CANCER (2008)
The LLP risk model: an individual risk prediction model for lung cancer
A. Cassidy et al.
BRITISH JOURNAL OF CANCER (2008)
Reproductive factors, hormone use, estrogen receptor expression and risk of non-small-cell lung cancer in women
Ann G. Schwartz et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
CYP17 genetic variation and risk of breast and prostate cancer from the national Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)
Veronica Wendy Setiawan et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Combination of polymorphisms from genes related to estrogen metabolism and risk of prostate cancers: The hidden face of estrogens
Olivier Cussenot et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Reproductive and hormonal factors and risk of lung cancer in women: A prospective cohort study
Geoffrey C. Kabat et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
A risk model for prediction of lung cancer
Margaret R. Spitz et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: A HuGE review
Sara H. Olson et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
The molecular epidemiology of lung cancer
Ann G. Schwartz et al.
CARCINOGENESIS (2007)
Meta- and pooled analysis of GSTT1 and lung cancer:: A HuGE-GSEC review
S. Raimondi et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2006)
Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features
IYS Tam et al.
CLINICAL CANCER RESEARCH (2006)
CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers:: a population-based study
AS Wenzlaff et al.
CARCINOGENESIS (2005)
Reproductive factors, hormone use and the risk of lung cancer among middle-aged never-smoking Japanese women: A large-scale population-based cohort study
Y Liu et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Genetic polymorphisms in the base excision repair pathway and cancer risk: A HuGE review
RJ Hung et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2005)
Estrogen receptor α increases basad and cigarette smoke extract-induced expression of CYP1A1 and CYP1B1, but not GSTP1, in normal human bronchial epithelial cells
W Han et al.
MOLECULAR CARCINOGENESIS (2005)
Nuclear estrogen receptor β in lung cancer:: Expression and survival differences by sex
AG Schwartz et al.
CLINICAL CANCER RESEARCH (2005)
The significance of estrogen receptor β in 301 surgically treated non-small cell lung cancers
CT Wu et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2005)
CYP19 (Aromatase) haplotypes and endometrial cancer risk
RA Paynter et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Estrogen receptor α and β are prognostic factors in non-small cell lung cancer
H Kawai et al.
CLINICAL CANCER RESEARCH (2005)
Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women
S Colilla et al.
PHARMACOGENETICS AND GENOMICS (2005)
Association of an aromatase TTTA repeat polymorphism with circulating estrogen, bone structure, and biochemistry in older women
IM Dick et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
GSTM1, GSTT1 and GSTP1 polymorphisms, environmental tobacco smoke exposure and risk of lung cancer among never smokers:: a population-based study
AS Wenzlaff et al.
CARCINOGENESIS (2005)
NQO1 T allele associated with decreased risk of later age at diagnosis lung cancer among never smokers:: results from a population-based study
CH Bock et al.
CARCINOGENESIS (2005)
Hormone replacement therapy and lung cancer risk: A case-control analysis
MB Schabath et al.
CLINICAL CANCER RESEARCH (2004)
A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men:: Effects on bone metabolism
L Gennari et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Hormonal factors and risk of lung cancer among women?
M Kreuzer et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2003)
Variations in lung cancer risk among smokers
PB Bach et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk
S Benhamou et al.
CARCINOGENESIS (2002)
Expression of estrogen receptors α and β in human lung tissue and cell lines
S Mollerup et al.
LUNG CANCER (2002)
Polymorphic variation in CYP19 and the risk of breast cancer
SW Baxter et al.
CARCINOGENESIS (2001)
Polymorphisms in the human aromatase cytochrome P450 gene (CYP19) and breast cancer risk
CS Healey et al.
CARCINOGENESIS (2000)